Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.46.6.1887-1895.2002
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2002
Authors
Publisher
American Society for Microbiology